SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-17-023192
Filing Date
2017-04-28
Accepted
2017-04-28 16:01:19
Documents
3
Period of Report
2017-05-25
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A v464772_def14a.htm DEF 14A 458372
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC spacer.gif GRAPHIC 43
  Complete submission text file 0001144204-17-023192.txt   459806
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37758 | Film No.: 17795305
SIC: 2834 Pharmaceutical Preparations